CareMax, Inc.
CMAXQ
OTC PK
| Weiss Ratings | CMAXQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | CMAXQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Very Weak | |||
| Beta / Standard Deviation | CMAXQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.39 | |||
| Price History | CMAXQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -- | |||
| 30-Day Total Return | -- | |||
| 60-Day Total Return | -- | |||
| 90-Day Total Return | -- | |||
| Year to Date Total Return | -- | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -- | |||
| 52-Week Low % Change | -- | |||
| Price | CMAXQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $16.32 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Jan 29, 2025 | |||
| 52-Week High Price (Date) | Mar 06, 2024 | |||
| Valuation | CMAXQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | -- | |||
| Enterprise Value | 496.78M | |||
| Price/Earnings (TTM) | 0.00 | |||
| Earnings Per Share (TTM) | -208.41 | |||
| Earnings Per Share Growth | -- | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.00 | |||
| Price/Book (Q) | 0.00 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | -- | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | CMAXQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 3.81M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | CMAXQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 786 360 4768 | |||
| Address | 1000 NW 57th Court Miami, FL 33126 | |||
| Website | www.caremax.com | |||
| Country | United States | |||
| Year Founded | -- | |||
| Profitability | CMAXQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -17.33% | |||
| Profit Margin | -99.78% | |||
| Management Effectiveness | CMAXQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -10.59% | |||
| Return on Equity | -- | |||
| Income Statement | CMAXQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 676.85M | |||
| Total Revenue (TTM) | 784.55M | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -25.95M | |||
| EBITDA (TTM) | -108.40M | |||
| EBIT (TTM) | -136.00M | |||
| Net Income (TTM) | -782.86M | |||
| Net Income Avl. to Common (TTM) | -782.86M | |||
| Total Revenue Growth (Q YOY) | -11.50% | |||
| Earnings Growth (Q YOY) | -426.80% | |||
| EPS Diluted (TTM) | -208.41 | |||
| EPS Diluted Growth (Q YOY) | -414.88% | |||
| Balance Sheet | CMAXQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 16.43M | |||
| Cash Per Share (Q) | $4.32 | |||
| Total Current Assets (Q) | 123.47M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -147.76M | |||
| Current Ratio (Q) | 0.233 | |||
| Book Value Per Share (Q) | -$38.73 | |||
| Total Assets (Q) | 454.04M | |||
| Total Current Liabilities (Q) | 529.67M | |||
| Total Debt (Q) | 513.21M | |||
| Total Liabilities (Q) | 601.80M | |||
| Total Common Equity (Q) | -147.76M | |||
| Cash Flow | CMAXQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -10.17M | |||
| Cash from Financing (TTM) | 23.76M | |||
| Net Change in Cash (TTM) | -38.17M | |||
| Levered Free Cash Flow (TTM) | -2.04M | |||
| Cash from Operations (TTM) | -51.76M | |||
